Journal profile · Medicine-Gastroenterology

Inflammatory Intestinal Diseases

ISSN 2296-9403 · eISSN 2296-9365 · Karger Publishers · Switzerland

Inflammatory Intestinal Diseases: fully open access; APC about USD 1,080; median 89 days to acceptance (73 articles, last 24 months); 47 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ3Gastroenterology · rank 93/176 · 47th percentile
Review time89 daysMedian, submission to acceptance · 73 articles, last 24 months · PubMed
APCUSD 1,080Fully open access
Acceptance—No reports yet
Articles per year472025 · OpenAlex count

Scope

Aims, scope and focus

Inflammatory Intestinal Diseases is published by Karger Publishers. By OpenAlex counts of its recent articles, its largest topics are Inflammatory Bowel Disease, Ocular Diseases and Behçet’s Syndrome and Microscopic Colitis, together about 60.2% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)

Imparting the most current information to physicians caring for patients with intestinal diseases, this journal aims to identify the basic pathophysiological mechanisms common to different inflammatory intestinal diseases, compare the environmental conditions involved in their pathogenesis, and provide important insights into their therapies. Inflammatory Intestinal Diseases thus reduces the gap between clinical and basic sciences as well as between hepatology and inflammatory diseases of the intestinal tract such as inflammatory bowel diseases, celiac disease, and irritable bowel syndrome. Inflammatory Intestinal Diseases also aims to improve the exchange of knowledge between researchers from Eastern and Western countries, which is reflected in the composition of the editorial board. The journal accepts randomized controlled clinical trials, observational studies, and cost-effectiveness analyses as well as commentary type and systematic reviews and consensus statements.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Gastroenterology

Editor-in-chief Toshifumi HibiPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology35.1%
  2. Ocular Diseases and Behçet’s SyndromeMedicine16.5%
  3. Microscopic ColitisMedicine8.6%
  4. Rheumatoid Arthritis Research and TherapiesMedicine5.4%
  5. Gut microbiota and healthBiochemistry, Genetics and Molecular Biology3.5%
  6. Eosinophilic EsophagitisMedicine3.2%
  7. Diverticular Disease and ComplicationsMedicine2.8%
  8. Pregnancy and Medication ImpactMedicine2.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
GastroenterologyQ393/17647th

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

PMCPubMedEmbasePublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
3LetPub ·
CiteScore (publisher)
3.6Publisher website ·
SJR 2026-06
0.54LetPub ·
SNIP 2026-06
0.59LetPub ·
h-index
32OpenAlex ·
i10-index
101OpenAlex ·
2-year mean citedness
1.5OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 344 in total · the current year is incomplete

YearArticlesOpen accessCitations
20264343440
20254747816
202433331,074
202323231,338
202214141,386
20213838927

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

89 daysMedian, submission to acceptance · P25–P75 66 days – 135 days

Acceptance to online
median 15 days (73 articles)
Submission to online
median 119 days
Sample
73 articles with submission and acceptance dates (86 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 20 weeksLetPub ·
Submission to final decision
112 daysPublisher website ·
Submission to publication (journal-reported)
about 24 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJCHF 980 / USD 1,080 / EUR 930YesCC BY, CC BY-NC
OpenAlexUSD 990 / EUR 850 / CHF 920——
LetPubEUR 930 / USD 1,080 / CHF 980Yes—
Publisher websiteUSD 1,230 / USD 980——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted15, with length limits
  1. brief reportailable below. For guidance purposes, a Brief Report is typically 3000 words in length and up to 3 Tables and Figures. Document Brief Remain text ≤ 3,000 words
  2. case reportailable below. For guidance purposes, a Case Report is typically 2500 words in length and up to 3 Tables and Figures. Document Case Repmain text ≤ 2,500 words
  3. commentaryailable below. For guidance purposes, a Commentary is typically 1000 words in length and up to 3 Tables and Figures. Document Commentamain text ≤ 1,000 words
  4. commentary typeThe journal accepts randomized controlled clinical trials, observational studies, and cost-effectiveness analyses as well as commentary type and systematic revi…Length not stated
  5. consensus statementsThe journal accepts randomized controlled clinical trials, observational studies, and cost-effectiveness analyses as well as commentary type and systematic revi…Length not stated
  6. cost-effectiveness analysesThe journal accepts randomized controlled clinical trials, observational studies, and cost-effectiveness analyses as well as commentary type and systematic revi…Length not stated
  7. editorialilable below. For guidance purposes, an Editorial is typically 1000 words in length and up to 3 Tables and Figures. Document Editoriamain text ≤ 1,000 words
  8. letterailable below. For guidance purposes, a Letter is typically 1000 words in length and up to 3 Tables and Figures. Document Letter Cmain text ≤ 1,000 words
  9. methods articleailable below. For guidance purposes, a Methods Article is typically 3000 words in length and up to 3 Tables and Figures. Documents Methodsmain text ≤ 3,000 words
  10. observational studiesThe journal accepts randomized controlled clinical trials, observational studies, and cost-effectiveness analyses as well as commentary type and systematic revi…Length not stated
  11. randomized controlled clinical trialsThe journal accepts randomized controlled clinical trials, observational studies, and cost-effectiveness analyses as well as commentary type and systematic revi…Length not stated
  12. research articleailable below. For guidance purposes, a Research Article is typically 5000 words in length with 4 to 8 Tables and Figures. Document Researchmain text ≤ 5,000 words
  13. review articleailable below. For guidance purposes, a Review Article is typically 5000 words in length with 4 to 8 Tables and Figures. Document Review Amain text ≤ 5,000 words
  14. systematic reviewailable below. For guidance purposes, a Systematic Review is typically 5000 words in length with 4 to 8 Tables and Figures. Document Systematmain text ≤ 5,000 words
  15. systematic reviewsThe journal accepts randomized controlled clinical trials, observational studies, and cost-effectiveness analyses as well as commentary type and systematic revi…Length not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Self-archiving
Authorship Author Contributions

In the Author Contribution statement, a short statement detailing the contributions of each person named as an author should be included. The CRediT taxonomy is a useful framework for preparing this section. Contributors to the submission who do not fulfil the ICMJE Criteria for Authorship should be credited, with their consent, in the Acknowledgement section.

Source ↗Publisher website ·
Conflicts of interest Conflict of Interest Statement

Authors are required to disclose any relationship that could be perceived as a conflict of interest in the Conflict of Interest Statement. All forms of support and financial involvement which took place in the previous three years should be listed, regardless of their potential relevance to the paper. Nonfinancial relationships that may potentially influence the writing of the manuscript should al…

Source ↗Publisher website ·
Data availability Data Availability Statement

Data Availability Statement required. Model summary

Authors are required to provide a Data Availability Statement that details whether data are publicly available and where the data supporting their study can be accessed. The journal’s data sharing policy strongly encourages authors to make all datasets on which the conclusions of the paper rely available to editors, reviewers and readers without unnecessary restriction wherever possible. In cases …

Source ↗Publisher website ·
Publication ethics

Statement of Ethics required. Model summary

The Statement of Ethics must provide detail about the ethical approval process for the study reported in the manuscript, including the name and affiliation of the committee who approved the study and the decision reference number.

Source ↗Publisher website ·
License & copyright Licenses and Copyright

License: Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Model summary

Articles published in Inflammatory Intestinal Diseases are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, unless otherwise agreed with Karger Publishers. When sharing or reusing any article, attribution must be given to the original source, using the statement "The final, published version of this article is available at http://karger.com/?d…

Source ↗Publisher website ·
Open access Open Access

Open Access since 2020 (All articles are published under Creative Commons licenses) Content prior to 2020 is available under the subscription model. All rights reserved.

Source ↗Publisher website ·
Peer review Peer Review

Peer review type: single-anonymous peer review system. Model summary

Peer Review Policy All Karger journals employ a rigorous peer-review process to confirm the validity and ensure scientific accuracy of published articles. Independent researchers with relevant expertise assess submitted manuscripts to help journal editors determine whether a manuscript should be published in their journal. All articles, except for Editorials and some Correspondence articles, are e…

Source ↗Publisher website ·
Self-archiving Archiving and Self-Archiving

All articles are archived in Portico. Articles may also be archived in PubMed Central if the journal is indexed there. Karger permits authors of Open Access articles to post the Version of Record (VOR) of their articles in Open Access repositories or on other websites. Preprints may be shared without restriction. Re-posted Open Access articles must follow the terms of the relevant Creative Commons…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Karger Publishers
Country or region
Switzerland
Language
English
ISSN
2296-9403
Electronic ISSN
2296-9365
Latest issue on the website
Volume 11, Issue 1 (December 2026)
Official links

FAQ

Frequently asked questions about Inflammatory Intestinal Diseases

How long does peer review take at Inflammatory Intestinal Diseases?

Based on the dates recorded on 73 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 89 days (interquartile range 66–135 days); authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Inflammatory Intestinal Diseases?

According to LetPub and DOAJ records, Inflammatory Intestinal Diseases is indexed in Scopus and DOAJ. The journal's website also lists PMC, PubMed and Embase; that list has not been checked against each database.

Is Inflammatory Intestinal Diseases open access, and what is the APC?

Inflammatory Intestinal Diseases is a fully open-access journal. APC about USD 1,080.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .